Stents Market Report 2026

Stents Market Overview

• Stents market size has reached to $11.81 billion in 2025 • Expected to grow to $15.62 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Growing Cardiovascular Disorders Fueling The Growth Of The Market Due To Increasing Demand For Medical Interventions • Market Trend: Recent Innovations In Drug-Eluting Stents: Terumo Ultimaster Nagomi Launch For Complex PCI • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stents Market?

A stent refers to a small, mesh-like tube that is inserted into a narrowed or blocked blood vessel to help keep it open and ensure proper blood flow. It is commonly used in medical procedures to treat conditions such as coronary artery disease and prevent arteries from collapsing after balloon angioplasty. The main products of the stents are coronary stents, peripheral stents, stent-related implants, biliary stents, carotid stents, and neurovascular stents. Coronary stents are small mesh tubes placed inside the heart's arteries to keep them open when they become narrowed or blocked due to plaque buildup. The various materials used are metallic biomaterials, polymer biomaterials, and natural biomaterials, and they are used by several end users, such as hospitals and clinics, ambulatory surgical centers, and others.

What Is The Stents Market Growth Forecast?

The stents market size is expected to see strong growth in the next few years. It will grow to $15.62 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to development of drug-eluting and bioabsorbable stents, expansion of neurovascular and peripheral interventions, rising investment in stent R&D, increasing aging population with cardiovascular conditions, integration of smart and AI-assisted stent deployment systems. Major trends in the forecast period include rising adoption of drug-eluting and bioabsorbable stents, increasing use of peripheral and neurovascular stents, focus on minimally invasive procedures and endovascular surgeries, growing demand for customized stent designs and materials, enhanced regulatory compliance and post-market surveillance.

Global Stents Market Segmentation

1) By Product: Coronary Stents, Peripheral Stents, Stent-Related Implants, Biliary Stents, Carotid Stents, Neurovascular Stents 2) By Material: Metallic Biomaterial, Polymer Biomaterial 3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End User Subsegments: 1) By Coronary Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents 2) By Peripheral Stents: Iliac Artery Stents, Femoral-Popliteal Artery Stents, Renal Artery Stents, Tibial Artery Stents 3) By Stent-Related Implants: Stent Grafts, Endovascular Stent Grafts, Covered Stents 4) By Biliary Stents: Plastic Biliary Stents, Metallic Biliary Stents, Self-Expanding Biliary Stents 5) By Carotid Stents: Balloon-Expandable Carotid Stents, Self-Expanding Carotid Stents 6) By Neurovascular Stents: Flow Diverter Stents, Self-Expanding Neurovascular Stents, Balloon-Expandable Neurovascular Stents

What Is The Driver Of The Stents Market?

The growing cardiovascular disorders are expected to propel the growth of the stents market going forward. Cardiovascular disorders are health problems that affect the heart or blood vessels, making it harder for the heart to work properly. The rise in cardiovascular disorders is due to a lack of physical activity, which can contribute to obesity, high blood pressure, and poor cardiovascular health by reducing the efficiency of the heart and circulation. Stent placement helps cardiovascular disorders by restoring and maintaining blood flow in narrowed or blocked arteries, thereby reducing the risk of heart attacks and other complications. For instance, in January 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, 7.6 million people in the UK were living with heart and circulatory diseases approximately 4 million men and 3.6 million women. These conditions contribute to nearly 27% of all deaths in the country, resulting in over 170,000 fatalities each year, or roughly 480 deaths every day. Therefore, the growing cardiovascular disorders are driving the growth of the stent industry.

Key Players In The Global Stents Market

Major companies operating in the stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical, Biotronik SE and Co KG, MicroPort Scientific Corporation, Meril Life Sciences, Biosensors International Group Ltd, Elixir Medical Corporation, Veryan Medical Limited, Vascular Concepts Ltd, Novatech SA, Merit Medical Systems Inc, Teleflex Incorporated, Micro Tech Europe, Balton Sp z oo, Endologix Inc, Cardinal Health Interventional, Nipro Medical Corporation, Optimed Medizinische Instrumente GmbH

Global Stents Market Trends and Insights

Major companies operating in the stent market are focusing on developing innovative technologies, such as drug eluting stents, to enhance efficacy, reduce restenosis rates, and improve patient outcomes. Drug eluting stents are small mesh tubes used in arteries that slowly release medication to help prevent the artery from narrowing again after being treated. For instance, in April 2023, Terumo Europe N.V., a Belgium-based medical device company, launched the Ultimaster Nagomi sirolimus-eluting coronary stent system for complex percutaneous coronary intervention (PCI) patients, following CE mark certification. This system is designed to improve deliverability in challenging anatomies, support shorter dual-antiplatelet therapy (DAPT) regimens for high bleeding-risk patients, and maintain optimal radial strength. It also integrates advanced polymer technology to ensure consistent drug release and enhanced endothelial healing.

What Are Latest Mergers And Acquisitions In The Stents Market?

In January 2024, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, acquired Taewoong Medical Co. Ltd. for $370 million. With this acquisition, Olympus aims to enhance its leadership in the gastrointestinal business by expanding its portfolio of innovative therapeutic stents, strengthening its presence in the global medical device market, and advancing its ability to provide comprehensive solutions for gastrointestinal disorders. Taewoong Medical Co. Ltd. is a South Korea-based company that manufactures medical devices, specifically specializing in the manufacturing of gastrointestinal (GI) metallic stents.

Regional Outlook

North America was the largest region in the stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Stents Market?

The stents market consists of sales of products such as renal artery stents, ureteral stents, and gastrointestinal stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.